vimarsana.com

Page 105 - பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mediterranean diet may decrease risk of prostate cancer progression

 E-Mail In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease. Men with prostate cancer are motivated to find a way to impact the advancement of their disease and improve their quality of life, said Justin Gregg, M.D., assistant professor of Urology and lead author of the study, published today in

Mediterranean diet may decrease risk of prostate cancer progression for men on active surveillance

Date Time Mediterranean diet may decrease risk of prostate cancer progression for men on active surveillance In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease. “Men with prostate cancer are motivated to find a way to impact the advancement of their disease and improve their quality of life,” said Justin Gregg, M.D., assistant professor of Urology and lead author of the study, published today in Cancer. “A Mediterranean diet is non-invasive, good for overall health and, as shown by this study, has the potential to effect the progression of their cancer.”

Single-Cell Transcriptome Profiling of Gastric Tumors Reveals Prognostic Gene Signature

Single-Cell Transcriptome Profiling of Gastric Tumors Reveals Prognostic Gene Signature January 6, 2021 Share The heterogeneity found within cancer tumors is both fundamentally important and poorly understood. Now, through single-cell transcriptome profiling of patients with gastric cancer, a team has developed and validated a gene expression signature capable of predicting patient survival better than other clinical features. If validated in further studies, this tool may be useful in stratifying patients with gastric cancer and directing them toward more effective treatment strategies. The work is published in Researchers from the University of Texas MD Anderson Cancer Center performed single-cell transcriptome profiling of peritoneal carcinomatosis (PC) from patients with gastric adenocarcinoma (GAC). For this study, the researchers isolated PC cells from ascites fluid collected from 20 patients with advanced gastric cancer. Ten of the patients were long-term survivors who s

Israelis Beat Cancer with Groundbreaking Microbiome Transplants

Jan 6, 2021 “For the first time in the world, we have successfully fought cancerous tumors by changing the gut microbiome,” says oncologist Dr. Ben Boursi. By Abigail Klein Leichman, Israel21c Changing the gut microbiome can reprogram the immune system to attack malignant tumors, according to results of a unique clinical trial at Sheba Medical Center in Israel. The results were published in the peer-reviewed journal Science by a research team led by senior GI oncologist Dr. Ben Boursi, senior oncologist Dr. Gal Markel and MD-PhD student Erez Baruch. “For the first time in the world, we have successfully fought cancerous tumors by changing the gut microbiome,” Boursi said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.